Jiangsu Simcere Pharmaceutical R&D Co., Ltd.
Records under this name other than patents Jiangsu Simcere Pharmaceutical R&D Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Jiangsu Simcere Pharmaceutical R&D Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,084,621 | 3-Pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,658,684 | Pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,986,692 | Anti-VEGF Monoclonal Antibody and Pharmaceutical Composition Comprising Said Antibody Formerly held In force · High confidence | In force | High confidence | |
| US 9,018,242 | Salt Form of Tyrosine Kinase Inhibitor Formerly held In force · High confidence | In force | High confidence | |
| US 8,802,824 | Modified Recombinant Human Endostatin and Uses Thereof Formerly held Lapsed on the fee record Ended Aug 12, 2026 · High confidence | Lapsed on the fee record | Ended Aug 12, 2026 | High confidence |
| US 7,008,921 | Materials and methods relating to endothelial cell growth inhibitors Lapsed on the fee record Ended Mar 7, 2014 · USPTO record | Lapsed on the fee record | Ended Mar 7, 2014 | USPTO record |